Open collaboration is important for sustainable science, and every new study or publication, no matter the journal or institution, contributes to a greater understanding of biology, for better or for worse. Dozens of prior discoveries funnel into every new breakthrough, so we need to appreciate the years of painstaking labor and thought that go into every new morsel of knowledge. It is very fulfilling when ABclonal products are part of the fuel that drives these studies in diverse fields of biology. With our ABclonal in Action series, we hope to highlight our products as well as the new insights from our customers all over the globe that will become stepping stones for the next generation of cutting-edge bioscience.

Cancer remains one of the most prevalent and deadly diseases affecting humanity. According to the Centers For Disease Control, cancer was the second leading cause of death in 2020 for Americans behind heart disease. The American Cancer Society projects at least 600,000 deaths due to cancer each year, despite the fact that mortality continues to decrease each year. The majority of these deaths are from advanced cancer, which are cancers that do not respond well to treatment and therefore cannot be cured. It is when the advanced cancer progresses to a point where it can escape the primary tumor site, a process known as metastasis, that the prognosis becomes grim.